skip to Main Content

Wellpartner acquires SMART solutions to provide next generation pharmacy services to Covered Entities

Wellpartner, Inc., (, a leading provider of pharmacy services, announces the signing of a definitive agreement to acquire a next generation split-billing and retail pharmacy gateway business, known as 340B SMART and 340B SMARTLINK. The acquisition will broaden and deepen Wellpartner’s existing 340B product suite, enabling the Company to offer complete, end-to-end 340B Program optimization to Covered Entities and their pharmacies.

340B SMART is currently being utilized by numerous Covered Entities’ internal pharmacies for split billing, ensuring both 340B compliance and the efficient management of pharmaceutical purchases. 340B SMARTLINK enables a pharmacy chain to effectively participate in 340B programs by insuring financial insight and control across all participating stores.

“We warmly welcome all of the new employees and Covered Entity clients to the Wellpartner team. Through our newly-combined strengths, we will continue to provide the industry’s best products, services and account management, and look forward to partnering closely with our new Covered Entity clients to optimize all aspects of their 340B Program,” said James R. Love, Wellpartner’s Chief Executive Officer.

Mr. Love added, “This acquisition goes well beyond the capacity to deliver an integrated split-billing product; it greatly accelerates our ability to provide next generation pharmacy services to the most important healthcare providers — 340B Covered Entities.”

340B SMART and SMARTLINK will be integrated seamlessly with Wellpartner’s CLARITY web portal. Once the integration is complete, clients will have access to an end-to-end product suite containing all the information and analytic tools necessary to optimize their 340B Programs. Clients will have a completely transparent view into the claims qualification of both their in-house and contracted pharmacies, maintaining consistent oversight and superior 340B qualification methodologies. Clients will also be afforded the ability to view and analyze their pharmaceutical purchases by clinic, facility and system, enabling the optimization of one of their largest and most important expense categories.

Back To Top